General anesthetics have marked effects on synaptic transmission, but the mechanisms of their presynaptic actions are unclear. We used quantitative laser scanning fluorescence microscopy to analyze the effects of the volatile anesthetic isoflurane on synaptic vesicle cycling in cultured neonatal rat hippocampal neurons monitored using either transfection of a pH sensitive form of green fluorescent protein fused to the lumenal domain of VAMP (synapto-pHlourin) or vesicle loading with the fluorescent dye FM 1-43. Isoflurane reversibly inhibited action potential-evoked exocytosis over a range of concentrations, with little effect on vesicle pool size. In contrast, exocytosis evoked by depolarization in response to an elevated extracellular concentration of KCl, which is insensitive to the selective Na + channel blocker tetrodotoxin, was relatively insensitive to isoflurane.
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Introduction
Despite intense interest and scrutiny, the detailed mechanisms by which general anesthetics alter neuronal function to produce amnesia, unconsciousness and immobility are unknown. Clinically relevant concentrations of general anesthetics preferentially affect synaptic transmission rather than axonal conduction (Larrabee & Posternak, 1952) by agent-specific postsynaptic and/or presynaptic mechanisms (MacIver, 1997) . Ligandgated ion channels are sensitive to clinical concentrations of many volatile and intravenous general anesthetics, and appear to underlie their postsynaptic effects (Franks & Lieb, 1994; Krasowski & Harrison 1999; Campagna et al., 2003) . Most general anesthetics enhance inhibitory synaptic transmission by potentiation of postsynaptic GABA A receptors (Tanelian et al., 1993) , while specific anesthetics such as nitrous oxide, xenon and ketamine depress excitatory synaptic transmission by blocking NMDA-type glutamate receptors with little effect on GABA A receptors (Lodge & Johnson, 1990; Mennerick et al., 1998; DeSousa et al., 2000; Yamakura & Harris, 2000) . In contrast, the synaptic effects of volatile anesthetics are not fully explained by postsynaptic actions on ligand-gated ion channels.
Volatile anesthetics depress excitatory synaptic transmission in the CNS by poorly characterized presynaptic mechanisms with little apparent contribution of postsynaptic AMPA-and NMDA-type glutamate receptor antagonism at clinical concentrations, as indicated indirectly by electrophysiological measurements of postsynaptic responses (Perouansky et al., 1995; MacIver et al., 1996) . Depression of glutamate release from isolated rat cerebrocortical nerve terminals evoked by pharmacological stimulation occurs at clinically relevant concentrations of volatile general anesthetics such as halothane and isoflurane (Schlame & Hemmings, 1995) . Isoflurane also inhibits the release of GABA from isolated nerve terminals, but with slightly lower potency than for glutamate (Westphalen & Hemmings, 2003) .
The small size of most nerve terminals in the CNS (diameter <1 µm) prohibits direct electrophysiological analysis of anesthetic effects on presynaptic action potentials and ion channel currents. The inability to directly monitor synaptic vesicle release further impedes detailed studies of presynaptic anesthetic mechanisms. Current electrophysiological and neurochemical techniques are inadequate for probing the effects MOL #3210 5 of general anesthetics on the exocytotic machinery. Analysis of a specialized giant brainstem auditory calyceal synapse in rat provided indirect evidence that isoflurane reduces exocytosis by suppressing presynaptic action potential amplitude modeled by reduced presynaptic current injections (Wu et al., 2004) . However the proposed highly non-linear coupling to exocytosis made it difficult to rule out other possible sites of action.
The effects of anesthetics on the endocytotic aspect of synaptic vesicle function are unknown. Genetic screening in C. elegans identified mutations in the three components of the core SNARE complex that alter anesthetic sensitivity complex, implicating SNARE mediated vesicle cycling as a target for presynaptic anesthetic effects (van Swinderen et al., 1999) , although this has not been confirmed in mammals. We used a recently developed optical technique that involves transfection of the pH dependent fluorescent probe super-ecliptic pHlourin fused to the lumenal domain of the synaptic vesicle SNARE protein VAMP to simultaneously monitor vesicle exocytosis/endocytosis (Sankaranarayanan et al., 2000) . This approach allowed us to determine the effects of the volatile anesthetic isoflurane on action potential-evoked synaptic vesicle cycling including both exocytosis and endocytosis in intact CNS neurons for the first time. Isoflurane at clinical concentrations inhibits action potential-evoked synaptic vesicle exocytosis in cultured rat hippocampal neurons without affecting endocytosis. This effect occurs MOL #3210 6 mounted in a rapid switching, laminar-flow perfusion and stimulation chamber (volume ~75 µl) on the stage of a custom-built laser scanning confocal microscope. Cells were continuously perfused at a rate of 1-1.5 ml/min at room temperature (~25°C) in Perfusion Buffer containing 119 mM NaCl, 2.5 mM KCl, 2 mM CaCl 2 , 2 mM MgCl 2 , 25 mM HEPES (buffered to pH 7.4), 30 mM glucose, 10 µM 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX; Research Biochemicals, Natick, MA) and 50 µM D,L-2-amino-5-phosphonovaleric acid (action potentialV; Research Biochemicals). Action potentials (action potentials) were evoked by passing 1 ms current pulses, yielding fields of ~10 V/cm, typically at 10 Hz for 20 sec (200 action potentials), through the chamber via platinum-iridium electrodes, which induces action potential firing with high fidelity (>90%). With stimulation of vesicle fusion, the pH-sensitive synapto-pHlorin, which is quenched by the low lumenal pH, is exposed to the extracellular solution generating an increase in fluorescence with expocytosis and a subsequent requenching of fluorescence with endocytosis. For dye studies, non-transfected cells were loaded with FM 1-43 (Molecular Probes, Eugene, OR) at a final concentration of 15 µM in Perfusion Buffer.
The entire releasable pool of vesicles (RP) was labeled by stimulating for 40-45 s at 30 Hz (a stimulus shown to turn over the entire RP at both 25°C and 35ºC) in the presence of the dye, followed by an additional 60 s of dye exposure to ensure labeling of all recycling membrane during endocytosis (Ryan & Smith, 1995) . Following 10 min of rinsing in dyefree solution, the unloading phase consisted of episodes of fluorescence image acquisition continuously during action potential firing. MOL #3210 7 puncta selected by hand. The same quantitative measurements were applied to the axonal surface, except that the 0.4 x 0.4 µm boxes spanned axonal areas in between individual boutons. Data are presented as the mean ∆F/F for control and drug treatments at each time point, and were analyzed by paired t test.
For FM dye experiments on non-transfected cells, each experiment corresponds to measurements from an individual cover-slip, which includes boutons from multiple neurons. For each cover-slip, a control experiment measured exocytosis without anesthetic, which was followed by reloading with FM dye, equilibration with a single concentration of isoflurane, and measurement of exocytosis in the presence of isoflurane.
Reversibility of the isoflurane effect was confirmed by washout of isoflurane, reloading with FM dye, and measurement of exocytosis without anesthetic. For the synapto-pHlorin studies, a low transfection frequency (~1%) allows monitoring of a single neuron per high (10-12 mM) was diluted with Perfusion Buffer into closed glass perfusion reservoirs to ~1.4-times the desired chamber concentration. In some experiments, bicuculline methiodide (Sigma Chemical Co., St. Louis MO) was added to both control and isoflurane containing Perfusion Buffer. The diluted isoflurane solutions were introduced to the perfusion chamber through polyethylene tubing from the closed glass reservoirs. Due the volatility of isoflurane and attendant losses (~30%), the final isoflurane concentrations exiting the perfusion chamber were determined by gas chromatography following extraction of the isoflurane into heptane (Ratnakumari & Hemmings, 1998) . This resulted in some scatter in the actual concentrations of isoflurane present in each experiment.
Except for the concentration-effect determination, a concentration of ~1 mM (~2.8 times the EC 50 for general anesthesia [MAC] in rat of 0.35 mM; Taheri et al., 1991) , which was This article has not been copyedited and formatted. The final version may differ from this version. for 10 min. Given the prominent potentiating effect of most intravenous and volatile general anesthetics on GABA A receptors (Franks & Lieb, 1994) , it is important to rule out an indirect depressive effect on excitability mediated by this mechanism as the reason for depression of excocytosis. Addition to the perfusion buffer of 10 µM bicuculline methiodide, a specific antagonist of GABA A receptors (Bai et al., 2001) , did not prevent the depression of action potential-evoked exocytosis by isoflurane (data not shown).
SpH measurements are well suited for examining concentration-dependent effects of pharmacological agents since repeated assays can be carried out on the same cell at multiple drug concentrations. The effect of isoflurane on action potential-evoked synaptopHlorin responses averaged from multiple boutons derived from a single transfected neuron was concentration-dependent ( Fig. 2A ). Similar measurements from additional neurons were used to assemble a concentration-effect curve for inhibition of synaptic vesicle cycling by isoflurane (Fig. 2B ). Significant inhibition of synapto-pHlorin responses occurred at the clinically relevant concentration of 0.43 mM isoflurane and above: 11±5% inhibition was observed at 0.43 mM (1.2 times EC 50 for general anesthesia; p<0.05, n=63 boutons). The average effect of three experiments near 2 times the EC 50 (~ED 95 ) for general anesthesia was 27±3% inhibition by 0.75±0.02 mM isoflurane (p<0.05). Complete blockade of exocytosis was obtained at the highest isoflurane concentrations tested (1.9 mM). The data were fit to a sigmoidal concentration-effect curve with IC 50 =1.0 mM and Hill slope=2.95 (r 2 =0.89).
Both exocytosis and endocytosis are slowed by isoflurane
The synapto-pHlorin signal reports a net balance of exocytosis and endocytosis (Sankaranaryanan & Ryan, 2001; Fernandez-Alfonso & Ryan, 2004) . A net positive change in fluorescence during the stimulus period indicates that the rate of exocytosis exceeded the rate of endocytosis (Fernandez-Alfonso & Ryan, 2004) . Thus, the reduction in peak fluorescence amplitude by isoflurane could result from suppression of exocytosis and endocytosis, suppression of exocytosis alone, or acceleration of endocytosis.
Following stimulation, synapto-pHlorin fluorescence recovers following zero-order kinetics, i.e. the initial rate of internalization is independent of the amount of synaptopHlorin to be internalized (Sankaranayanan & Ryan, 2000) and endocytosis proceeds at a This article has not been copyedited and formatted. The final version may differ from this version. constant rate both during and immediately after the stimulus period (Sankaranarayanan & Ryan, 2001 ). An appropriate measure of the speed of endocytosis is the initial rate of synapto-pHlorin fluorescence change following the stimulus period. We therefore analyzed the initial decay rate of synapto-pHlorin fluorescence for the first 3 time points post stimulus in the absence and presence of isoflurane. Isoflurane (1.04±0.5 mM) suppressed the synapto-pHlorin peak response by 54±2.7%, and slowed the post-stimulus endocytosis rate by 52±8% (p<0.05 for each by paired t-test, n=4, Fig. 3 ).
Since the synapto-pHlorin signal represents the net difference between exocytosis and endocytosis, isoflurane must inhibit exocytosis as well. We therefore examined the effect of isoflurane on the kinetics of FM 1-43 destaining, which should give a faithful measure of its impact on action potential-evoked exocytosis. Synaptic vesicles were labeled with FM 1-43 using repetitive electrical stimulation at 20 Hz to elicit rounds of exocytosis/endocytosis. Following washing, the dye released by exocytosis upon subsequent stimulation in the absence or presence of isoflurane was quantified by timelapse fluorescence imaging of labeled boutons. Following a control dye loading/unloading experiment, the same terminals were reloaded with dye and superfused with buffer containing isoflurane during a second round of dye unloading (Fig. 4) Figure 6 . Although the very late phase of endocytosis is somewhat slower in the presence of isoflurane at 10 Hz compared to a control at 7.3 Hz, the initial post-stimulus slopes (as defined in Fig. 3 ) were almost identical (ratio of the post-stimulus endocytosis slope in isoflurane to the frequencyshifted control=0.95±0.1; p>0.05 by paired t-test, n=4). Thus isoflurane inhibition of synapto-pHlorin responses is most consistent with an effective block of action potential firing.
This article has not been copyedited and formatted. The final version may differ from this version. The available data cannot distinguish between anesthetic blockade of axonal Na + channels that support axonal action potential conduction (Mikulec et al., 1998 ) from blockade of Na + channels in the presynaptic bouton that are required for sufficient nerve terminal deplolarization to activate the voltage-gated Ca 2+ channels coupled to exocytosis (Nicholls, 1993) . Evidence from isolated nerve terminals (Schlame & Hemmings, 1995; OuYang et al., 2003) and the calyx of Held (Wu et al., 2004) suggest that inhibition of Na + channels in the presynaptic bouton is sufficient to inhibit transmitter release, though a contribution from depression of axonal action potential conduction may also be involved (Mikulec et al., 1998 influx (MacIver et al., 1996; Kirson et al., 1998) , and a study in isolated guinea pig nerve This article has not been copyedited and formatted. The final version may differ from this version. (Miao et al., 1995) , though this finding was not reproducible (Lingamaneni et al., 2001 ). However, pharmacological evidence indicates that the principal target for inhibition of glutamate release from isolated rat, mouse and guinea pig cortical nerve terminals occurs at a target upstream of the voltage-gated Ca 2+ channels coupled to exocytosis (Ratnakumari & Hemmings, 1998; Lingamaneni et al., 2001; Westphalen et al., 2003) . Electrophysiological studies in isolated rat neurohypophysial nerve terminals indicate that isoflurane potently inhibits presynaptic voltage-gated Na + channels (OuYang et al., 2003) and action potential amplitude with a less potent effect on Ca 2+ channels (Ouyang et al., 2005) , consistent with our results in hippocampal neurons. In the calyx of Held synapse stimulated by intraterminal current injections, isoflurane inhibited exocytosis detected by presynaptic capacitance changes and reduced the amplitude of presynaptic action potentials (Wu et al., 2004) . Voltagegated N-and P/Q-type Ca 2+ channels (Ca v 2.1 and 2.2) have been implicated as the source of presynaptic Ca 2+ entry in hippocampal synaptic transmission (Wheeler et al., 1994; Wu & Saggau, 1994) . Despite findings that somatic and heterologously expressed N-and P/Q-type voltage-gated Ca 2+ channels can be inhibited by volatile anesthetics (Study, 1994; Kamatchi et al., 1999) , the available evidence (reduced sensitivity of KCl-evoked exocytosis, no Ca 2+ rescue) does not support presynaptic Ca 2+ channel bloackade as the principal target for depression of transmitter release by volatile anesthetics.
This study supports the hypothesis that depression of excitatory synaptic transmission by volatile anesthetics can be accounted for largely by presynaptic mechanisms.
Specifically, inhibition of exocytosis by the volatile anesthetic isoflurane occurs primarily upstream of Ca 2+ influx. Our results can be explained by a reduction in nerve terminal excitation due to impaired action potential conduction within the presynaptic bouton resulting in impaired synaptic efficiency. In fact, the effects of isoflurane on synaptic vesicle cycling are mimicked by application of the selective Na + channel blocker tetrodotoxin (data not shown) or by reducing the number of action potential stimuli.
Pharmacological evidence in isolated nerve terminals indicates that blockade of presynaptic voltage-gated Na + channels is the probable mechanism for this effect, though effects on K + channels cannot be ruled out. Volatile anesthetics inhibit Na + channelThis article has not been copyedited and formatted. The final version may differ from this version. Ryan, unpublished observations). We have also shown that isoflurane inhibits release of both glutamate and GABA from isolated rat cortical nerve terminals by an independent dual label isotopic method (Westphalen & Hemmings, 2003) , though GABA release is somewhat less sensitive than glutamate release. This heterogeneity may explain some of the variation observed in sensitivity of exocytosis to isoflurane in individual neurons.
Considerable uncertainty has surrounded the mechanisms of action of general anesthetics for more than a century (Franks & Lieb, 1994; Campagna et al., 2003 This article has not been copyedited and formatted. The final version may differ from this version. This article has not been copyedited and formatted. The final version may differ from this version.
